2BB score and signals
Rapport Therapeutics, Inc.’s current 2BB score is 11 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 12 | Very Low |
| Momentum | 50 | Stable |
| Financial strength | 48 | Normal |
| Quality | 80 | Very Strong |
| Risk | 44 | Moderate |
Company facts
| Headquarters | Boston, Massachusetts, United States |
| Founded | 2022 |
| Employees | 84 |
| 52-week range | $11.05 – $42.27 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-03-08 | — | -1.2482 | — | $0.00 |
| 2026-11-05 | — | -1.234 | — | $0.00 |
| 2026-08-06 | — | -0.9733 | — | $0.00 |
| 2026-05-06 | — | -0.6865 | — | $5.83M |
2BBBullish & Bearish